th
The studentships are open to UK/EU students and will provide a stipend and full fees in a number of research areas across the University. Interested applicants should have, or expect to gain, a good first degree in a relevant subject. Due to the highly competitive nature of this studentship, only candidates with, or expecting,
1 st class degrees can be considered.
Email your application and supporting documents to Martha Smith: fbsgrad@leeds.ac.uk
Please include the following with your application:

Full CV

Transcript of degree examination marks

Two academic references/testimonials
Title (Miss/Ms/Mrs/Mr) Surname (Family Name) First Name(s)
Country of Birth Nationality Gender (M/F) Date of Birth
Month Day Year
Permanent Home Address Correspondence Address (with dates)
Tel No:
E-Mail:
Tel No:
E-Mail:
Academic Qualifications (including any for which you are currently aiming):
Name of Dates Qualification Obtained
University/Institution Start Finish (eg BA/BSc) and Main
Degree
Classification (eg 1 st
Subject Area Class Honours)
Grade (GPA) or
Percentage
Mark eg 3.5/4.0
/
/
/

Surname (Family Name) First Name(s)
Proposed project (choose a maximum of 3 from the list in appendix I:
1
2
3
Please outline why you are interested in your chosen project(s) and include any information about previous research experience.
Word Count: (Maximum of 500 words)

Project title
Tumorigenicity in a CIZ1 deletion mouse model
Combining next-generation sequence data with sparser genotyping to identify inherited genetic variants affecting predisposition to or relapse from cancer
Cross talk between the IGF axis and the G protein coupled oestrogen receptor (GPR30) in development of resistance to adjuvant therapy in breast cancer.
Barrett, Jennifer
Beattie, James
Investigation of cancer stem like-cells in ovarian cancer
Bell, Sandra
Improving melanoma survival: understanding the genetic epidemiology of chronic inflammation and vitamin D levels in melanoma patients
Development of novel oncolytic adenoviruses for pancreatic cancer therapy
Main Supervisor
Ainscough, Justin
Dept
FOMH: AU Cardiovascular Medicine
(Inst Genetics
Health/Therapeutics(LIGHT))
FOMH: LIMM
Bishop, Tim
Blair, Eric
FOMH: Oral Biology (Leeds Dental
Institute)
FOMH: Section of Ophthalmology &
Neuroscience (Leeds Institute of
Molecular Medicine (LIMM))
FOMH: Section of Epidemiology &
Biostatistics (Leeds Institute of
Molecular Medicine (LIMM))
FBS: School of Molecular and Cellular
Biology
“Cut-and-Run”: A New Mechanism by which Aberrant
Recombination Reactions could Trigger Lymphoid cancers
Boyes, Joan
Burchill, Susan Cellular pathways involved in the development and maintenance of cancer-initiating drug-resistant cells responsible for treatment failure and relapse.
Manipulation of immune cells to enhance tumour immunity
Cook, Graham
Identification of novel biomarkers for renal cell carcinoma.
Craven, Rachel
FBS: School of Molecular and Cellular
Biology
FOMH: Section of Experimental
Oncology (Leeds Institute of Molecular
Medicine (LIMM))
FOMH: Section of Oncology & Clinical
Research (Leeds Institute of Molecular
Medicine (LIMM))
FOMH: Section of Oncology & Clinical
Research (Leeds Institute of Molecular
Medicine (LIMM))
Food Science Genetic polymorphisms and impact of dietary polyphenols on catechol-O-methyltransferase (COMT) and estrogen metabolism in breast cancer
Day, Andrea
Targeting Syk (spleen tyrosine kinase) as therapy for
Multiple Myeloma
Doody, Gina FOMH: Section of Experimental
Haematology (Leeds Institute of
Molecular Medicine (LIMM))
MAPS: School of Chemistry Computer-Aided Design, Synthesis, and Biological
Evaluation of New Inhibitors of FGFR Kinases for the
Treatment of Bladder Cancer
Fishwick, Colin
Small molecule inhibitors of Orai channels as possible therapeutics for treating colorectal cancer and associated liver metastases
Foster, Richard
Antiviral Therapy for non-Hodgkin Lymphoma Griffin, Stephen
MAPS: School of Chemistry
Inhibition of p53 aggregation as a therapeutic target in cancer
Hewitt, Eric
FOMH: Section of Oncology & Clinical
Research (Leeds Institute of Molecular
Medicine (LIMM))
FBS: School of Molecular and Cellular
Biology

Anti-cancer drug delivery: developing a predictive in silico model to improve chemotherapy drug delivery
Hubbard, Matthew MAPS: Artificial Intelligence & Biological
Sys (School of Computing)
Cross-talk between tumour-associated macrophages and cancer cells: a target for the anticolorectal cancer activity of omega-3 polyunsaturated fatty acids
Hull, Mark
The role of splicing factor ESRP1 in disease progression and chemoresistance
Hurst, Carolyn
Identifying genetic variants underlying susceptibility to multiple cancers through statistical meta analysis
Iles, Mark
Targeting P2X7 receptors to prevent cancer metastasis
Jiang, Lin-Hua
FOMH: Section of Molecular
Gastroenterology (Leeds Institute of
Molecular Medicine (LIMM))
FOMH: Section of Experimental
Oncology (Leeds Institute of Molecular
Medicine (LIMM))
FOMH: Section of Epidemiology &
Biostatistics (Leeds Institute of
Molecular Medicine (LIMM))
FBS: School of Biomedical Sciences
Uncovering the role of primary cilia in the development of cancer
Mutational and functional analysis of epigenetic modifier genes implicated in bladder cancer
Oncolytic virotherapy for brain tumours.
Johnson, Colin
Knowles, Margaret
Lorger, Mihaela
Molecular mechanisms and therapeutic interventions of virus-induced cancer metastasis
Macdonald, Andrew
FOMH: Section of Ophthalmology &
Neuroscience (Leeds Institute of
Molecular Medicine (LIMM))
FOMH: Section of Experimental
Oncology (Leeds Institute of Molecular
Medicine (LIMM))
FOMH: Section of Experimental
Oncology (Leeds Institute of Molecular
Medicine (LIMM))
FBS: School of Molecular and Cellular
Biology
Evaluating the therapeutic efficacy of ROCK inhibition in brain cancer
Understanding cancer mediated suppression of
Natural Killer cell anti-tumour activity.
Mavria, Georgia
Meade, Josephine
FOMH: Section of Oncology & Clinical
Research (Leeds Institute of Molecular
Medicine (LIMM))
FOMH: Oral Biology (Leeds Dental
Institute)
Mumps, measles and rubella (MMR) for the oncolytic virotherapy of cancer.
Non-invasive bio-electronic sensing of secreted factors in seminal plasma as indicators of prostatic pathology.
Melcher, Alan
Miller, David
FOMH: Section of Oncology & Clinical
Research (Leeds Institute of Molecular
Medicine (LIMM))
FOMH: Repro & Early Dev Research
(RED) Group (Centre for Epidemiology
& Biostatistics)
FBS: School of Biomedical Sciences Development of electrochemical biosensors for routine screening of colorectal cancer biomarkers
Millner, Paul
Identification of the genetic characteristics of melanoma tumours associated with different patterns of host response
Newton-Bishop, Julia FOMH: Section of Epidemiology &
Biostatistics (Leeds Institute of
Molecular Medicine (LIMM))
How do changes in specific myosin isoforms promote metastasis in Prostate Cancer?
Peckham, Michelle FBS: School of Molecular and Cellular
Biology

Radiotherapy target definition, adaptation and response prediction in head and neck tumours: combining DCE-MRI with PET/CT
Sourbron, Steven
Using 3D organotypic models of the normal human mammary gland to explore the role of HER2 and other oncogenes in breast cancer initiation
Speirs, Valerie
Investigating Non-coding RNAs in tumour associated macrophages
Stacey, Martin
FOMH: AU Medical Physics (Inst
Genetics Health/Therapeutics(LIGHT))
FOMH: Section of Pathology (Leeds
Institute of Molecular Medicine (LIMM))
FBS: School of Molecular and Cellular
Biology
Using RNA aptamers to study cellular targets of human papillomavirus oncoproteins
Stonehouse, Nic FBS: School of Molecular and Cellular
Biology
Studying the role of protein kinases in cancer cells Tomlinson, Darren FBS: School of Molecular and Cellular
Biology
From images to understanding: modelling cancer using virtual slides
Treanor, Darren FOMH: Section of Pathology (Leeds
Institute of Molecular Medicine (LIMM))
Molecular mechanisms and therapeutic interventions of virus-induced cancer metastasis
Whitehouse, Adrian FBS: School of Molecular and Cellular
Biology
Silver-N-heterocyclic carbene (NHC) complexes for selective cancer therapeutics; development of a
‘silver-NHC generator’ for clinical use.
Inhibition of KSHV Protease: a Novel Therapeutic
Strategy for Treatment of KSHV-associated malignancies
Therapeutic targeting of the BTB-domain protein,
BCL6, in B-cell lymphoma
Willans, Charlotte
Wilson, Andrew
Wright, Stephanie
MAPS: School of Chemistry
MAPS: School of Chemistry
FBS: School of Molecular and Cellular
Biology
Semantic support for cancer trials: an Oncology
Ontology Workbench to unlock the research potential of linked datasets
Wyatt, Jeremy FOMH: Yorkshire Centre for Health
Informatics (Leeds Institute of Health
Sciences)